Get all your news in one place.
100's of premium titles.
One app.
Start reading
Los Angeles Times
Los Angeles Times
Comment
Ashish Thakrar

Commentary: Why are we denying people with opioid addiction the most effective treatment?

When you receive a scary diagnosis — for cancer, heart disease or other serious illness — one of your first calls is probably to a doctor who can offer the full range of evidence-based care. But if your diagnosis were for opioid addiction and you came to see me, an addiction specialist, federal regulations written half a century ago would bar me from prescribing the most effective treatment: methadone.

The U.S. lost more than 100,000 people to overdoses in 2021 in a crisis now dominated by fentanyl and other synthetic drugs. That’s more than twice the number of deaths at the height of the HIV/AIDS epidemic in 1995. When officially tallied, overdose deaths in 2022 will also exceed 2020 levels.

Last month, the FDA made naloxone — the safe and effective drug that can reverse an overdose as it’s happening, of which Narcan is the best-known brand — available over the counter. If manufacturers set an affordable price, expanded access to naloxone could save countless lives. Expanded access to methadone would do the same.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.